“La Médecine d’après, leçons du Covid 19”
In this essay, Michel Goldman discusses the lessons from the pandemic that should influence medicine as a whole. After tracing the evolution of anti-infective strategies, he explains how the study of rare diseases […]
Financial Intermediation and the Funding of Biomedical Innovation: A Review by Andrew W. Lo and Richard T. Thakor
A key paper on financing biomedical innovation: link here.
Review of literature on financial intermediation in the process by which new medical therapeutics are financed, developed, and delivered.
International Conference – Decentralisation of health care : European experiences
DULBEA, Solidaris & CIRIEC – 16th of November – Dupréel Room (ULB Solbosch)
In collaboration with Solidaris and CIRIEC, the DULBEA is organising an international conference on the 16th of November 2022 in the Dupréel room at the […]
Register now to the Interdisciplinary Program
Registrations for the 8th edition of the Interdisciplinary Program is now open.
Full program will be available soon.
Please find all the information on our dedicated page: here
Article: Covid long: portrait du grand imitateur du 21e siècle
Le Pr Michel Goldman (Professeur émérite d’immunologie et président de l’Institut interdisciplinaire pour l’innovation en santé à l’ULB) vient de publier un article consacré au Covid long dans Frontiers of Medicine. Il en commente les […]
Quel intérêt pour le dosage des anticorps anti-Covid ?
Quel intérêt pour le dosage des anticorps anti-Covid ? Ci-dessous les réponses de Michel Goldman à Laurence Dardenne dans La Libre.
- Comment mesure-t-on le taux d’anticorps?
Le test sérologique Covid-19 consiste en […]